Medicines And Healthcare Products Regulatory

Rediff.com » News » Medicines And Healthcare Products Regulatory

News for Medicines And Healthcare Products Regulatory

News
Business

Doctors not prescribing generic drugs to be penalised

All doctors must prescribe generic drugs, failing which they will be penalised and even their license to practice may also be suspended for a period, according to the new regulations issued by the......

WHO issues alert against syrup by Indian manufacturer

The World Health Organisation on Tuesday issued a product alert over contaminated syrup by an Indian manufacturer, warning that it is unsafe for use, especially in children, and may result in......

Molnupiravir not to be included in Covid treatment now

The Indian Council of Medical Research's national task force for COVID-19 has decided against including antiviral drug Molnupiravir in the clinical management protocol for COVID-19 as of now,......

UK's new antibody treatment against Covid may work against Omicron

The UK's medicines regulator on Thursday approved a new antibody treatment against COVID-19, which it believes will also be effective against new variants such as Omicron. IMAGE: A nurse prepares......

Pressure on UK to review Covid vax rules for Indians

The UK government is under increasing pressure on Monday to review its COVID-19 vaccine protocol in place for travellers from India, after its updated rules effective from next month failed to......

Pharma funds: 'Enter with a horizon of 5-7 years or more'

In contrast with their strong performance in 2020 and 2021, pharmaceutical and healthcare funds experienced a decline in 2022, with returns plummeting by an average 9.8 per cent. Photograph: Yves......

Key mantra for India's pharma sector in 2023

Reinvent and innovate will be the key mantra for the Indian pharma industry in the New Year as the 'pharmacy of the world' looks to move from volume to value leadership, amid emerging challenges of......

Flipkart promotes several leaders as it gears up for blockbuster IPO

Flipkart has promoted several of its leaders into newer roles at a time when the Walmart-owned e-commerce giant has internally raised its IPO (initial public offering) valuation target to about $60......

Who will win the Super App race in India?

A super app is the golden key to the customer for any company selling products or services at the retail level. Illustration: Dominic Xavier/Rediff.com Unlike the race to buy airwaves by telecom......

Home healthcare could be one of India's best bets

One of the biggest impediments to growth for this sector is the fact that home healthcare in India is not covered by insurance. In Delhi’s Greater Kailash, Alka Sahni began to panic as her......

Rediff News

Medicines And Healthcare Products Regulatory

News for Medicines And Healthcare Products Regulatory

Doctors not prescribing generic drugs to be penalised

WHO issues alert against syrup by Indian manufacturer

Molnupiravir not to be included in Covid treatment now

UK's new antibody treatment against Covid may work against Omicron

Pressure on UK to review Covid vax rules for Indians

Pharma funds: 'Enter with a horizon of 5-7 years or more'

Key mantra for India's pharma sector in 2023

Flipkart promotes several leaders as it gears up for blockbuster IPO

Who will win the Super App race in India?

Home healthcare could be one of India's best bets

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS